Navigation Links
Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes
Date:9/12/2008

surgery independent of weight.

Session VIII: Novel Gastrointestinal Interventional Therapies
(11:00 a.m. 12:15 p.m.)

Speakers and panelists will discuss how a better understanding of GI surgery for diabetes, and recent technological developments, are creating the foundation for novel and revolutionary, minimally invasive interventional therapies that may have the same effects of surgery. New endoscopic and endoluminal therapies for diabetes, as well as gastric and intestinal stimulator devices, will be presented, including early clinical trials from the United States, South America and Europe.

New data from a pilot clinical trial will be presented showing that an endoluminal gastrointestinal device may prevent nutrients from contacting the upper part of the small bowel, achieving immediate and sustained improvement of diabetesindependent of weight losssuggesting a direct action on the mechanisms of disease.

Findings will be presented by Dr. Lee Kaplan, an associate professor of medicine at Harvard Medical School, and the director of the Weight Center at Massachusetts General Hospital in Cambridge, Massachusetts.

Session IX: Clinical and Research Recommendations for Diabetes Surgery: The Rome Consensus Conference
(1:15 p.m. 2:45 p.m.)

Outcomes of the First International Consensus Conference (the Rome Diabetes Surgery Summit), which examined the use of surgical intervention for diabetes, will be publicly presented for the first time. This session is held under the auspices of the International Diabetes Surgery Task Force, a group of leading scholars from around the world, including some of the most respected diabetes experts, clinical trials specialists, surgeons and scientists. The Task Force has been created to promote the recommendations established by the voting experts of the Rome Summit worldwide.

The Diabetes Surgery Summit guidelines, which include recommendations for the
'/>"/>

Contact: John Rodgers
jdr2001@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
2. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
3. Coalition to Protect Floridas Drivers Applauds Governor Crist for Adding PIP to Special Session
4. Couples attending counseling sessions together better prepared to ease childrens concerns
5. Following Heart Disease Guidelines Saves Lives, According to a Kaiser Permanente Abstract Presented at AHA Scientific Sessions
6. Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientific Sessions
7. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
8. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
9. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
10. Society of Gynecologic Oncologists 39th Annual Meeting on Womens Cancer to Include Sessions on HPV and Cervical Cancer
11. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... This news release is available in French . ... breakthrough could revolutionize surgical practice and regenerative medicine. A ... Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur ... and Paris 13), has just demonstrated that the principle ... used in vivo to repair soft-tissue organs and tissues. ...
(Date:4/17/2014)... identified new pain relief targets that could be ... researchers at King,s College London made the discovery ... the periphery of the body. , Dr Marzia ... mechanisms underlying pain generation and our findings could ... effects." , One potential side effect of some ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... School of Medicine (BUSM) have discovered that the ... experimental model. The findings, reported in the ... may lead to more effective treatments for alcoholism. ... the leading causes of illness and death in ... by limiting the productivity of workers and necessitating ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... phone use on the road: studies , MONDAY, Sept. 28 ... difference in your teen,s safety once he or she gets ... firm rules, but do so in a helpful, supportive way, ... auto accident by half and decrease rates of drinking and ...
... 2009 Researchers at UT Southwestern Medical Center ... and lung cancer have become more prevalent among ... of anti-retroviral therapies in the mid-1990s. ... higher risk for so-called AIDS-defining malignancies cancers ...
... are invited to attend a gathering of the nation,s leading ... and develop programs that may help lower the nation,s costly ... held Oct. 8 and 9 in Arlington, Virginia, is a ... of Obstetricians and Gynecologists, the American Academy of Pediatrics, American ...
... approach to understanding how cells develop resistance to drugs has ... Anderson Cancer Center a New Innovator Award from the National ... M. D. Anderson,s Department of Systems Biology, will receive $1.5 ... NIH announced awards Thursday in three prestigious programs that fund ...
... Warning follows report that dosing instructions for liquid medication ... News) -- U.S. health officials have issued a public ... errors involving liquid Tamiflu for kids. , The alert, ... parents could give the wrong dose of Tamiflu to ...
... ... recognized in 42 states, gives consumers control over healthcare costs, saving time and money ... Philadelphia, ... out-patient physical therapy clinic with eight locations throughout the Philadelphia region, indicate that awareness ...
Cached Medicine News:Health News:Firm Parents Keep Teen Drivers Safe 2Health News:Firm Parents Keep Teen Drivers Safe 3Health News:Certain cancers more common among HIV patients than non-HIV patients 2Health News:Experts to review quality improvement programs to prevent preterm birth 2Health News:Experts to review quality improvement programs to prevent preterm birth 3Health News:M. D. Anderson scientist wins NIH New Innovator Award 2Health News:M. D. Anderson scientist wins NIH New Innovator Award 3Health News:FDA Issues Health Alert on Kids' Tamiflu Dosages 2Health News:FDA Issues Health Alert on Kids' Tamiflu Dosages 3Health News:According to Excel Physical Therapy and Fitness, Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Doctor's Prescription 2Health News:According to Excel Physical Therapy and Fitness, Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Doctor's Prescription 3
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Pa., Oct. 29 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today ... Credit Suisse Healthcare Conference to be held November 10-12, 2010 ... Fickenscher, Chief Financial Officer, is scheduled to present an overview ... ET on Thursday, November 11, 2010. To listen ...
... Calif., Oct. 28 VIVUS, Inc. (Nasdaq: ... Response Letter (CRL) from the U.S. Food and Drug ... the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The ... the NDA cannot be approved in its present form. ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 2FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 4FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 5
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: